-
2
-
-
10444267194
-
Inter-observer agreement in the assessment of endoscopic findings in ulcerative colitis
-
de Lange T, Larsen S, Aabakken L. Inter-observer agreement in the assessment of endoscopic findings in ulcerative colitis. BMC Gastroenterol 2004;4:9
-
(2004)
BMC Gastroenterol
, vol.4
, pp. 9
-
-
de Lange, T.1
Larsen, S.2
Aabakken, L.3
-
3
-
-
33845928428
-
Conduct of clinical trials in ulcerative colitis: impact of independent scoring of endoscopic severity on results of a randomised controlled trial with a peptide and 5ASA
-
Travis SPL, Cooney R, Lukas M, et al. Conduct of clinical trials in ulcerative colitis: impact of independent scoring of endoscopic severity on results of a randomised controlled trial with a peptide and 5ASA. Am J Gastroenterol 2006;101:S429
-
(2006)
Am J Gastroenterol
, vol.101
, pp. S429
-
-
Travis, S.P.L.1
Cooney, R.2
Lukas, M.3
-
4
-
-
84895466364
-
Comparing disease activity indices in ulcerative colitis
-
Walsh AJ, Ghosh A, Brain A, et al. Comparing disease activity indices in ulcerative colitis. J Crohns Colitis 2014;8:318-25
-
(2014)
J Crohns Colitis
, vol.8
, pp. 318-325
-
-
Walsh, A.J.1
Ghosh, A.2
Brain, A.3
-
5
-
-
84857700568
-
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity [UCEIS]
-
Travis SPL, Schnell D, Krzeski P, et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity [UCEIS]. Gut 2012;61:535-42
-
(2012)
Gut
, vol.61
, pp. 535-542
-
-
Travis, S.P.L.1
Schnell, D.2
Krzeski, P.3
-
6
-
-
33847179443
-
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis
-
D'Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007;132:763-6
-
(2007)
Gastroenterology
, vol.132
, pp. 763-766
-
-
D'Haens, G.1
Sandborn, W.J.2
Feagan, B.G.3
-
7
-
-
84879485530
-
The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis
-
Feagan BG, Sandborn WJ, D'Haens G, et al. The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis. Gastroenterology 2013;145:149-57
-
(2013)
Gastroenterology
, vol.145
, pp. 149-157
-
-
Feagan, B.G.1
Sandborn, W.J.2
D'Haens, G.3
-
8
-
-
84886775628
-
Reliability and initial validation of the Ulcerative Colitis Endoscopic Index of Severity
-
Travis SPL, Schnell D, Krzeski P, et al. Reliability and initial validation of the Ulcerative Colitis Endoscopic Index of Severity. Gastroenterology 2013;145:987-95
-
(2013)
Gastroenterology
, vol.145
, pp. 987-995
-
-
Travis, S.P.L.1
Schnell, D.2
Krzeski, P.3
-
9
-
-
84973148626
-
Clinical trial endoscopy and central reading of endoscopy endpoints for inflammatory bowel disease
-
[in press]
-
Gottlieb K, Travis SPL, Sandborn WJ, Hussain F, Feagan BG, Rutgeerts P. Clinical trial endoscopy and central reading of endoscopy endpoints for inflammatory bowel disease. Inflamm Bowel Dis 2015 [in press]
-
(2015)
Inflamm Bowel Dis
-
-
Gottlieb, K.1
Travis, S.P.L.2
Sandborn, W.J.3
Hussain, F.4
Feagan, B.G.5
Rutgeerts, P.6
-
10
-
-
24644495105
-
RDP58 is a novel and potentially effective oral therapy for ulcerative colitis [UC]: results of parallel prospective, multicenter, blinded, placebo-controlled trials
-
Travis SPL, Yap LM, Hawkey CJ, et al. RDP58 is a novel and potentially effective oral therapy for ulcerative colitis [UC]: results of parallel prospective, multicenter, blinded, placebo-controlled trials. Inflamm Bowel Dis 2005;11:713-9
-
(2005)
Inflamm Bowel Dis
, vol.11
, pp. 713-719
-
-
Travis, S.P.L.1
Yap, L.M.2
Hawkey, C.J.3
-
11
-
-
70649110836
-
Delayed-release oral mesalamine 4.8 g/day [800-mg tablet] is effective for patients with moderately active ulcerative colitis
-
e1-3
-
Sandborn WJ, Regula J, Feagan BG, et al. Delayed-release oral mesalamine 4.8 g/day [800-mg tablet] is effective for patients with moderately active ulcerative colitis. Gastroenterology 2009;137:1934-43.e1-3
-
(2009)
Gastroenterology
, vol.137
, pp. 1934-1943
-
-
Sandborn, W.J.1
Regula, J.2
Feagan, B.G.3
-
12
-
-
0002294347
-
A simple sequentially rejective multiple test procedure
-
Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70
-
(1979)
Scand J Stat
, vol.6
, pp. 65-70
-
-
Holm, S.1
-
13
-
-
0017381382
-
An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers
-
Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977;33:363-74
-
(1977)
Biometrics
, vol.33
, pp. 363-374
-
-
Landis, J.R.1
Koch, G.G.2
-
14
-
-
0023521441
-
Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study
-
Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987;317:1625-9
-
(1987)
N Engl J Med
, vol.317
, pp. 1625-1629
-
-
Schroeder, K.W.1
Tremaine, W.J.2
Ilstrup, D.M.3
-
15
-
-
59849104111
-
Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis
-
Lewis JD, Chuai S, Nessel L, Lichtenstein GR, Aberra FN, Ellenberg JH. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis 2008;14:1660-6
-
(2008)
Inflamm Bowel Dis
, vol.14
, pp. 1660-1666
-
-
Lewis, J.D.1
Chuai, S.2
Nessel, L.3
Lichtenstein, G.R.4
Aberra, F.N.5
Ellenberg, J.H.6
-
16
-
-
84922885438
-
P150 Responsiveness of endoscopic indices in the evaluation of ulcerative colitis
-
Levesque BG, Loftus EV, Panaccione R, et al. P150 Responsiveness of endoscopic indices in the evaluation of ulcerative colitis. J Crohns Colitis 2014;8:S124
-
(2014)
J Crohns Colitis
, vol.8
, pp. S124
-
-
Levesque, B.G.1
Loftus, E.V.2
Panaccione, R.3
-
17
-
-
84991271258
-
Correlation between the Ulcerative Colitis Endoscopic Index of Severity [UCEIS] and outcomes in acute severe ulcerative colitis
-
March 13. [Epub ahead of print.]
-
Corte CJ, Fernandopulle N, Catuneanu A, et al. Correlation between the Ulcerative Colitis Endoscopic Index of Severity [UCEIS] and outcomes in acute severe ulcerative colitis. J Crohns Colitis 2015 March 13. pii: jjv047. [Epub ahead of print.]
-
(2015)
J Crohns Colitis
-
-
Corte, C.J.1
Fernandopulle, N.2
Catuneanu, A.3
-
18
-
-
84941260661
-
Selecting Therapeutic Targets in Inflammatory Bowel Disease [STRIDE]: determining therapeutic goals for treat-to-target
-
[in press]
-
Peyrin Biroulet L, Sandborn WJ, Sands B, et al. Selecting Therapeutic Targets in Inflammatory Bowel Disease [STRIDE]: determining therapeutic goals for treat-to-target. Am J Gastroenterol 2015 [in press]
-
(2015)
Am J Gastroenterol
-
-
Peyrin Biroulet, L.1
Sandborn, W.J.2
Sands, B.3
-
19
-
-
84870888253
-
Validation of the ulcerative colitis colonoscopic index of seversity and its correlation with disease activity measures
-
Samuel S, Bruinning DH, Loftus EV, et al. Validation of the ulcerative colitis colonoscopic index of seversity and its correlation with disease activity measures. Clin Gastroenterol Hepatol 2013;11:49-54
-
(2013)
Clin Gastroenterol Hepatol
, vol.11
, pp. 49-54
-
-
Samuel, S.1
Bruinning, D.H.2
Loftus, E.V.3
-
20
-
-
79955796048
-
Measurement of disease activity in ulcerative colitis: interobserver agreement and predictors of severity
-
Thia KT, Loftus EV, Pardi DS, et al. Measurement of disease activity in ulcerative colitis: interobserver agreement and predictors of severity. Inflamm Bowel Dis 2011;17:1257-64
-
(2011)
Inflamm Bowel Dis
, vol.17
, pp. 1257-1264
-
-
Thia, K.T.1
Loftus, E.V.2
Pardi, D.S.3
|